Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
Clinical trial NCT00537524 · COMPLETED
Trial details
- NCT number
- NCT00537524
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2007-10-01
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.